Works matching IS 03624803 AND DT 2024 AND VI 67 AND IP 11

Results: 4

Preliminary Research of Radiolabeled Atezolizumab for the Noninvasive Evaluation of TNBC PD‐L1 Expression In Vivo.
Published in:
Journal of Labelled Compounds & Radiopharmaceuticals, 2024, v. 67, n. 11, p. 384, doi. 10.1002/jlcr.4122
By:
- He, Shuhua;
- Jia, Lina;
- Zheng, Xiaobei;
- Wang, Yang;
- Liu, Yuxia;
- Zhang, Lan
Publication type:
Article
Lead‐212/Bismuth‐212 In Vivo Generator Based on Ultrasmall Silver Telluride Nanoparticles.
Published in:
Journal of Labelled Compounds & Radiopharmaceuticals, 2024, v. 67, n. 11, p. 375, doi. 10.1002/jlcr.4121
By:
- Wang, Runze;
- Wolterbeek, Hubert Th.;
- Denkova, Antonia G.
Publication type:
Article
<sup>68</sup>Ga Radiolabeling of NODASA‐Functionalized Phage Display–Derived Peptides for Prospective Assessment as Tuberculosis‐Specific PET Radiotracers.
Published in:
Journal of Labelled Compounds & Radiopharmaceuticals, 2024, v. 67, n. 11, p. 360, doi. 10.1002/jlcr.4120
By:
- Gouws, Christiaan A.;
- Naicker, Tricia;
- de la Torre, Beatriz G.;
- Albericio, Fernando;
- Duvenhage, Janie;
- Kruger, Hendrik G.;
- Marjanovic‐Painter, Biljana;
- Mdanda, Sipho;
- Zeevaart, Jan R.;
- Ebenhan, Thomas;
- Govender, Thavendran
Publication type:
Article
Issue Information.
Published in:
Journal of Labelled Compounds & Radiopharmaceuticals, 2024, v. 67, n. 11, p. 357, doi. 10.1002/jlcr.4040
Publication type:
Article